Lyubov Zholudeva

Statistics

Publications

Citations

404

H-Index

Active since

2019

Affiliations

Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center"(Current)

UPMC Hillman Cancer Center

Institut Gustave Roussy

Seoul National University Hospital

University of Milan

Lyubov Zholudeva is an author at Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center" specializing in cancer immunotherapy, durvalumab therapy, and immunotherapy.

Publications per year

2019–2020

Publications

Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

Robert L. Ferris, Robert I. Haddad, Caroline Even et al. · Annals of Oncology · 2020 · 365 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

EAGLE: A phase 3, randomized, open-label study of durvalumab (D) with or without tremelimumab (T) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC).

Lisa Licitra, Robert I. Haddad, Caroline Even et al. · Journal of Clinical Oncology · 2019 · 39 citations

Medicine, Oncology, Pharmacology +16

1–2 of 2